Evidence map›Paper›PMID 41057472›Full record

ArticleScientific reports2025

A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.

Carlo Saija, Sukruth Pradeep Kundur, Lisa Leung, Sachin Sabu, Marco Pinto, Mark Herridge, Adharvan Gabbeta, Rashi Chavan, Nadia M Chowdhury, Gregory Gibson and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Carlo SaijaSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. carlo.saija@kcl.ac.uk.
Sukruth Pradeep KundurSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Lisa LeungSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Sachin SabuSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Marco PintoSt Thomas Hospital, London, UK.
Mark HerridgeSt Thomas Hospital, London, UK.
Adharvan GabbetaSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Rashi ChavanSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Nadia M ChowdhurySchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Gregory GibsonSt Thomas Hospital, London, UK.
Calum ByrneSt Thomas Hospital, London, UK.
Antonia PontikiSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Richard James HousdenSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Pierre Berthet-RayneCaranx Medical, Nice, France.
Jonathan M BeharSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Kawal RhodeSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Funding

Vitro Diagnostic Co-operative (MIC) Award for Cardiovascular Diseases to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London MIC-2016-019Wellcome Centre for Medical Engineering at King's College London WT203148/Z/16/ZWellcome Trust
6 · The paper itself

Abstract

In the growing field of electrophysiology, cardiac ablation either via heating or freezing target tissues using catheters, induces localised scarring to block or destroy defective electrical pathways in the heart. To test equipment and ablation settings, studies have resorted to ex-vivo and in-vivo models including pigs, dogs, and chickens. The use of animal tissue presents ethical and logistical complications and introduces variability between samples and between studies. In a scientific community faced with progressively more stringent ethics and regulations on animal testing, a more practical and ethical alternative should be established. To meet this need, multiple studies have proposed tissue-mimicking materials. However, either toxicity or poorly matched physical properties, prevented these materials from reaching widespread application. Furthermore, no material has yet been identified to test both cryoablation and radiofrequency ablation. Here, we present a novel thermochromic alginate hydrogel material that can simulate ablation lesions for both radiofrequency ablation and cryoablation. This material could find direct applications in electrophysiology, but adapted mixtures could also be used to recreate other tissues for different simulations.

Indexed as

Catheter AblationCryosurgeryPhantoms, ImagingRadiofrequency AblationAnimalsDogsHydrogelsMyocardiumSwineHydrogels

Identifiers

PMID41057472
PMCPMC12504574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.